Share
Market Research Report

CELLULAR IMMUNOTHERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Therapy TypeCAR T-Cell Therapy (Chimeric Antigen Receptor T-cell) · TCR-T Cell Therapy (T-Cell Receptor T-cell) · NK Cell Therapy (Natural Killer cell therapy) · Dendritic Cell Therapy · Tumor-Infiltrating Lymphocytes (TIL) Therapy · Macrophage-Based Cell Therapy · and Others (emerging/novel cell types)
  • By SourceAutologous (patient-derived cells) and Allogeneic (donor-derived cells)
  • By IndicationCancer (Hematologic Malignancies (e.g., leukemia, lymphoma, myeloma), Solid Tumors (e.g., lung, breast, melanoma, ovarian, glioblastoma)) · Infectious Diseases (Viral Infections (e.g., HIV, HBV, HCV, COVID-19), Bacterial Infections (e.g., tuberculosis)) · Autoimmune Disorders (Multiple Sclerosis, Rheumatoid Arthritis, Type 1 Diabetes) · and Others
  • By Manufacturing ModalityEx Vivo Cell Expansion and In Vivo Engineering
  • By End UserHospitals and Clinics · Specialty Endocrinology and Obesity Centers · Ambulatory Surgical Centers (ASCs) · Home Healthcare Services · and Others (Academic and Research Institutes, etc.)
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In10 Mar 2026
  • Report CodeCMI8447
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Cellular Immunotherapy Market, By Therapy Type
      • Global Cellular Immunotherapy Market, By Source
      • Global Cellular Immunotherapy Market, By Indication
      • Global Cellular Immunotherapy Market, By Manufacturing Modality
      • Global Cellular Immunotherapy Market, By End User
      • Global Cellular Immunotherapy Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Cellular Immunotherapy Market, By Therapy Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • CAR T-Cell Therapy (Chimeric Antigen Receptor T-cell)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • TCR-T Cell Therapy (T-Cell Receptor T-cell)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • NK Cell Therapy (Natural Killer cell therapy)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Dendritic Cell Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Tumor-Infiltrating Lymphocytes (TIL) Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Macrophage-Based Cell Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others (emerging/novel cell types)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Cellular Immunotherapy Market, By Source, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Autologous (patient-derived cells)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Allogeneic (donor-derived cells)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Cellular Immunotherapy Market, By Indication, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Hematologic Malignancies (e.g., leukemia, lymphoma, myeloma)
          • Solid Tumors (e.g., lung, breast, melanoma, ovarian, glioblastoma)
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Viral Infections (e.g., HIV, HBV, HCV, COVID-19)
          • Bacterial Infections (e.g., tuberculosis)
    • Autoimmune Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
        • Multiple Sclerosis
          • Rheumatoid Arthritis
          • Type 1 Diabetes
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Cellular Immunotherapy Market, By Manufacturing Modality, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Ex Vivo Cell Expansion
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • In Vivo Engineering
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Cellular Immunotherapy Market, By End User, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals and Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Specialty Endocrinology and Obesity Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Ambulatory Surgical Centers (ASCs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Home Healthcare Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others (Academic and Research Institutes, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Cellular Immunotherapy Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Manufacturing Modality, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  10. Competitive landscape

    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Gilead Sciences Inc (Kite Pharma)
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bristol Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson and Johnson (Janssen Biotech)
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Cellectis S.A.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Adaptimmune Therapeutics plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Autolus Therapeutics plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Allogene Therapeutics Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Atara Biotherapeutics Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Legend Biotech Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • bluebird bio Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Fate Therapeutics Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • ImmunityBio Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Iovance Biotherapeutics Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Poseida Therapeutics Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  11. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'Cellular Immunotherapy Market' - Global forecast to 2033